Vitamin D Supplementation in Diabetic Nephropathy

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

Also called NCT01476501

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01476501
Other papers using this trial's data
  • Vitamin D3 supplementation, bone health and quality of life in adults with diabetes and chronic kidney disease: Results of an open label randomized clinical trial Clinical nutrition (Edinburgh, Scotland), 2017-06 DOI, PubMed 27302208

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01476501. Randomized; no masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2014-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Vitamin D Supplementation in Diabetic Nephropathy
Condition
Sub-optimal Vitamin D Status
Condition
Bone Disease
Condition
Diabetic Nephropathy
Intervention (Drug)
Vitamin D3
Lead sponsor
University of Alberta (class: other)

Record details

Record id
cardio:ct-nct01476501
Content hash
2dcb83971de9c50c112feee76f55b5b709a4212a819b68007404bfc085294f6b